Investor’s Business Daily |
Sanofi, Regeneron Dip As Eczema Drug Dupixent Lags In Europe
Investor’s Business Daily Sanofi (SNY) and Regeneron Pharmaceuticals' (REGN) Dupixent is off to a strong start in the U.S., but revenue from the eczema drug lagged in Europe, an analyst said Wednesday after Sanofi's fourth-quarter report. X Dupixent generated 118 million euros … |
Tag Archives: Drug
FDA clears new drug application for topical psoriasis treatment
AD drug development driven by symptom and disease control
Drug development for established atopic dermatitis focuses on both managing flares and long-term disease control.
Dermatology Times – Dermatology
Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis – AJMC.com Managed Markets Network
|
Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis
AJMC.com Managed Markets Network This new study suggests that dupilumab's ability to quickly reduce inflammation, which makes it so effective in clearing up atopic dermatitis (eczema), appears to be at work in reversing type 2 inflammation in eosinophilic esophagitis. Dupilumab works … |
Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis – AJMC.com Managed Markets Network
|
Eczema Drug Shows Promising Phase 2 Results for Treatment of Eosinophilic Esophagitis
AJMC.com Managed Markets Network This new study suggests that dupilumab's ability to quickly reduce inflammation, which makes it so effective in clearing up atopic dermatitis (eczema), appears to be at work in reversing type 2 inflammation in eosinophilic esophagitis. Dupilumab works … |
FDA challenges abuse-deterrent opioid drug claim
The FDA pushes back on new painkiller’s abuse-deterrent claims. Here’s why this is important to the opioid epidemic.
Managed Healthcare Executive – Health Management
Drug for refractory psoriatic arthritis shows promise in clinical trial
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided…
Eczema / Psoriasis News From Medical News Today
SkinSmart Antimicrobial debuts with eczema and wound care … – Drug Store News
Drug Store News |
SkinSmart Antimicrobial debuts with eczema and wound care …
Drug Store News MINNEAPOLIS — SkinSmart Antimicrobial is a new skincare brand launching over-the-counter solutions for eczema and wound care. SkinSmart is powered by … SkinSmart Antimicrobial Launches Innovations for Eczema … |
SkinSmart Antimicrobial debuts with eczema and wound care … – Drug Store News
Drug Store News |
SkinSmart Antimicrobial debuts with eczema and wound care …
Drug Store News MINNEAPOLIS — SkinSmart Antimicrobial is a new skincare brand launching over-the-counter solutions for eczema and wound care. SkinSmart is powered by … SkinSmart Antimicrobial Launches Innovations for Eczema … |
SkinSmart Antimicrobial debuts with eczema and wound care … – Drug Store News
Drug Store News |
SkinSmart Antimicrobial debuts with eczema and wound care …
Drug Store News MINNEAPOLIS — SkinSmart Antimicrobial is a new skincare brand launching over-the-counter solutions for eczema and wound care. SkinSmart is powered by … SkinSmart Antimicrobial Launches Innovations for Eczema & Wounds |